# Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

> **NCT06976073** · — · RECRUITING · sponsor: **HJN Sverige AB/Neko Health** · enrollment: 8000 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetic Foot
- Peripheral Arterial Disease
- Skin Cancer
- Cardiovascular Disease Risk

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06976073
- **Lead sponsor:** HJN Sverige AB/Neko Health
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 8000 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06976073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06976073, "Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06976073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
